Cargando…
Translational issues in precision medicine in neuropathic pain
Neuropathic pain remains poorly treated, with most new drugs falling through the translational gap. The traditional model of bench-to-bedside research has relied on identifying new mechanisms/targets in animal models and then developing clinical applications. Several have advocated bridging the tran...
Autores principales: | Dickenson, Anthony H., Patel, Ryan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077367/ https://www.ncbi.nlm.nih.gov/pubmed/32258972 http://dx.doi.org/10.1080/24740527.2020.1720502 |
Ejemplares similares
-
Mechanisms of the gabapentinoids and α
(2)
δ‐1 calcium channel subunit in neuropathic pain
por: Patel, Ryan, et al.
Publicado: (2016) -
Neuronal hyperexcitability in the ventral posterior thalamus of neuropathic rats: modality selective effects of pregabalin
por: Patel, Ryan, et al.
Publicado: (2016) -
Neuropathic low back pain in clinical practice
por: Baron, R., et al.
Publicado: (2016) -
A study of cortical and brainstem mechanisms of diffuse noxious inhibitory controls in anaesthetised normal and neuropathic rats
por: Patel, Ryan, et al.
Publicado: (2019) -
Translational investigation and treatment of neuropathic pain
por: Xu, Bo, et al.
Publicado: (2012)